全文获取类型
收费全文 | 397篇 |
免费 | 15篇 |
国内免费 | 8篇 |
专业分类
耳鼻咽喉 | 2篇 |
儿科学 | 20篇 |
妇产科学 | 6篇 |
基础医学 | 31篇 |
口腔科学 | 6篇 |
临床医学 | 42篇 |
内科学 | 92篇 |
皮肤病学 | 4篇 |
神经病学 | 13篇 |
特种医学 | 79篇 |
外科学 | 60篇 |
综合类 | 26篇 |
预防医学 | 13篇 |
眼科学 | 2篇 |
药学 | 10篇 |
中国医学 | 1篇 |
肿瘤学 | 13篇 |
出版年
2022年 | 2篇 |
2021年 | 3篇 |
2020年 | 4篇 |
2019年 | 5篇 |
2018年 | 7篇 |
2017年 | 4篇 |
2016年 | 7篇 |
2015年 | 7篇 |
2014年 | 11篇 |
2013年 | 14篇 |
2012年 | 13篇 |
2011年 | 17篇 |
2010年 | 25篇 |
2009年 | 18篇 |
2008年 | 11篇 |
2007年 | 15篇 |
2006年 | 17篇 |
2005年 | 17篇 |
2004年 | 5篇 |
2003年 | 9篇 |
2002年 | 6篇 |
2001年 | 7篇 |
2000年 | 9篇 |
1999年 | 10篇 |
1998年 | 25篇 |
1997年 | 28篇 |
1996年 | 16篇 |
1995年 | 13篇 |
1994年 | 20篇 |
1993年 | 10篇 |
1992年 | 5篇 |
1991年 | 2篇 |
1990年 | 5篇 |
1989年 | 7篇 |
1988年 | 8篇 |
1987年 | 4篇 |
1986年 | 6篇 |
1985年 | 3篇 |
1983年 | 1篇 |
1982年 | 1篇 |
1981年 | 6篇 |
1980年 | 1篇 |
1979年 | 2篇 |
1978年 | 1篇 |
1977年 | 4篇 |
1975年 | 1篇 |
1969年 | 1篇 |
1968年 | 3篇 |
1967年 | 2篇 |
1966年 | 1篇 |
排序方式: 共有420条查询结果,搜索用时 125 毫秒
71.
72.
73.
Coste I Le Corf K Kfoury A Hmitou I Druillennec S Hainaut P Eychene A Lebecque S Renno T 《The Journal of clinical investigation》2010,120(10):3663-3667
Accumulating evidence points to inflammation as a promoter of carcinogenesis. MyD88 is an adaptor molecule in TLR and IL-1R signaling that was recently implicated in tumorigenesis through proinflammatory mechanisms. Here we have shown that MyD88 is also required in a cell-autonomous fashion for RAS-mediated carcinogenesis in mice in vivo and for MAPK activation and transformation in vitro. Mechanistically, MyD88 bound to the key MAPK, Erk, and prevented its inactivation by its phosphatase, MKP3, thereby amplifying the activation of the canonical RAS pathway. The relevance of this mechanism to human neoplasia was suggested by the finding that MyD88 was overexpressed and interacted with activated Erk in primary human cancer tissues. Collectively, these results show that in addition to its role in inflammation, MyD88 plays what we believe to be a crucial direct role in RAS signaling, cell-cycle control, and cell transformation. 相似文献
74.
JU Brorholt-Petersen HK Jensen B Raungaard N Gregersen O Faergeman 《Clinical genetics》2001,59(6):397-405
Studies of the cholesterol lowering effect of statin therapy as a function of low-density lipoprotein (LDL)-receptor mutation type have not produced a clear picture, possibly because they included patients with several different kinds of LDL-receptor mutations. We studied the response to treatment with fluvastatin in 28 patients with heterozygous familial hypercholesterolemia as a result of a receptor-negative mutation (Trp23-stop) and in 30 patients with a receptor-binding defective mutation (Trp66-Gly) to test the hypothesis that response to treatment depends on the type of mutation. Patients were randomized to 12 weeks of treatment with fluvastatin 40 mg daily and 12 weeks of placebo treatment, preceded by a placebo run-in period of 8 weeks in a double-blind, cross-over design. Untreated plasma concentrations of lipids and lipoproteins were similar in the two groups of patients. Plasma cholesterol and LDL cholesterol response to therapy tended to be less marked in receptor-binding defective patients, but the differences were not statistically significant. A tabulation of the results of the present and earlier studies suggests that differences in treatment response as an apparent function of LDL-receptor gene mutational type occur mainly in populations with recent genetic admixture (<400 years). In such populations, persons with the same mutation in the LDL-receptor gene are more likely to share other but undetermined genetic variations affecting the pharmacology of statins. 相似文献
75.
76.
Full-frame transform compression of CT and MR images 总被引:3,自引:0,他引:3
77.
Oral lesions of HIV infection in developing countries 总被引:3,自引:0,他引:3
HIV infection has spread rapidly within developing countries since it was first recognized in the early 1980s. The purpose of this paper is to review the prevalence of oral lesions associated with HIV infection (oral HIV) in the developing world, and to identify additional factors that may complicate the presentation of these lesions. Direct comparison of regional and local prevalence studies within Africa, India and Thailand is speculative because there are few reports available. Furthermore, inherent differences in study design, data collection, standardization and calibration of health workers make any inferences inconclusive. Additional prevalence studies of oral HIV lesions associated with systemic disease or social conditions, such as poverty or malnutrition, are needed. In order to provide a basis for the diagnosis and treatment of HIV-associated oral lesions in the developing world, it is important to recognize any confounding factors that may impact on their presentation and management. Elucidation of these various factors may provide a basis for treatment within the developing and developed world. 相似文献
78.
79.
80.
HK Iversen 《Cephalalgia : an international journal of headache》1995,15(4):281-287
The need for valid human experimental models of headache is obvious. Several compounds have been proposed as headache-inducing agents, but only the nitroglycerin (NTG) model has been validated. In healthy subjects, intravenous infusions of the nitric oxide (NO) donor NTG induce a dose-dependent headache and dilatation of the temporal, radial and middle cerebral artery. NTG-induced headache, although less intense, resembles migraine in pain characteristics, but the accompanying symptoms are rarely present. Cephalic large arteries are dilated during migraine headache as well as during NTG headache. N-acetylcysteine enhances the formation of NO and potentiates NTG-induced headache, whereas mepyramine, a H1 -antagonist capable of blocking histamine-induced headache, has no effect. Thus, the headache is dependent on NO or other steps in the NO cascade. The model is useful for pharmacological interventions and sumatriptan reduced the NTG-induced headache. The NTG model may be a valuable tool in the development of future migraine drugs. 相似文献